“initial-public-offering” Archives

in
Entry Author Date Location
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials 04/13/17 San Diego
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work 11/17/16 Texas
CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul 10/18/16 Boston
Leap Therapeutics Seeks Public Markets With Macrocure Merger 08/29/16 Boston
Gemphire’s Delayed $30M IPO Will Pay for Trials of Cholesterol Drug 08/10/16 Detroit Ann Arbor
Inspyr, Formerly GenSpera, Replaces Co-Founder Dionne With New CEO 08/04/16 Texas
Web Communications Company Twilio Raises $150M in IPO 06/22/16 San Francisco
RA Capital Seeds Peanut Allergy Prevention Startup With $1.7M 06/01/16 Boston
Pfizer Invests in Wave, Inks Metabolic-Focused Drug Development Deal 05/05/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
From California to New York, Fintech Finds Loans for Almost Anyone 01/20/16 National
Flash Sale: Web Retailer Gilt Groupe Sells to Hudson Bay for $250M 01/07/16 New York
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
Expedia Buys Austin’s HomeAway for $3.9B 11/04/15 Texas
SolarWinds Bought for $4.5B in Austin’s Second Megadeal 10/21/15 Texas
Spiceworks New CFO Brings Lessons From Twitter to IT Networking 09/29/15 Texas
Texas Roundup: Favor, UT-San Antonio, Yan Engines, Health Wildcatters 08/28/15 Texas
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO 08/24/15 Texas
RainDance Technologies Cancels Long-Awaited IPO 08/24/15 Boston
Seattle E-Retailer Zulily Sells to QVC In Deal Worth $2.4 Billion 08/17/15 Seattle
Roundup: New Money for FlexGen, Neos, MacroFab, Castle & Other News 08/03/15 Texas
Boston’s HubSpot Axes Marketing Exec Over Book Manuscript 07/29/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug 07/07/15 San Francisco
Page 1 of 3 next page »